Shed and LTR Pharma Execute Definitive Commercial Agreement to Bring ROXUS® to Patients Across the United States
SALT LAKE CITY, July 21, 2026 /PRNewswire/ -- Shed has announced the execution of a definitive commercial agreement with LTR Pharma, formalizing the companies' partnership to commercialize ROXUS®, LTR Pharma's rapid-onset intranasal treatment for erectile dysfunction, across the United...
SALT LAKE CITY, July 21, 2026 /PRNewswire/ -- Shed has announced the execution of a definitive commercial agreement with LTR Pharma, formalizing the companies' partnership to commercialize ROXUS®, LTR Pharma's rapid-onset intranasal treatment for erectile dysfunction, across the United...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.